iRhythm Technologies (IRTC) revenue breakdown
By product, Contracted third-party payors is the largest at 52% of fiscal 2025 revenue, growing 32% a year over 7 years.
Revenue by product
Fiscal years, as iRhythm Technologies reports them in its 10-K filings; fiscal 2025 total $747M.
| Products | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|
| Contracted third-party payors | $57M | $102M | $136M | $194M | $224M | $267M | $312M | $392M | 52% |
| Centers for Medicare and Medicaid | $40M | $59M | $73M | $45M | $103M | $122M | $142M | $179M | 24% |
| Healthcare institutions | $37M | $43M | $41M | $57M | $60M | $71M | $95M | $126M | 17% |
| Non-contracted third-party payors | $12M | $11M | $15M | $27M | $24M | $32M | $43M | $50M | 7% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for IRTC.
Open IRTC in InvestinglyQuestions
Where does iRhythm Technologies make its money?
In fiscal 2025, by product: Contracted third-party payors $392M, Centers for Medicare and Medicaid $179M, Healthcare institutions $126M, Non-contracted third-party payors $50M.
From iRhythm Technologies's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.